Literature DB >> 13678701

[D-Ala2, D-Leu5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat.

Kousyou Yamanouchi1, Katsuhiko Yanaga, Sadayuki Okudaira, Susumu Eguchi, Junichiro Furui, Takashi Kanematsu.   

Abstract

BACKGROUND: [D-Ala(2), D-Leu(5)] enkephalin (DADLE) is a synthetic delta class of opioid and is reported to induce hibernation as well as hibernation induction trigger (HIT) in the serum of hibernating mammals. DADLE and HIT have been demonstrated to protect the heart, lung, and jejunum against ischemia-reperfusion (I-R) injury. In the present study, we examined the effect of DADLE on I-R injury of the liver in rats.
METHODS: After administration of DADLE (DADLE group) or normal saline as a vehicle (Control group), partial hepatic ischemia was induced by occluding the vessels supplying 92% of the liver for 45 min, followed by declamping the vessels and resection of the non-ischemic lobe. After 120 min of reperfusion, serum glutamic-pyruvic transaminase (GPT), hyaluronic acid (HA) levels, and concentrations of malondialdehyde (MDA) of the liver tissue were measured. Additionally, bile output from the ischemic lobes was measured after reperfusion.
RESULTS: GPT levels were significantly lower in the DADLE group as compared to those of the Control group (P < 0.05), but the serum levels of HA were not different between the two groups. The concentrations of MDA of the liver tissue were significantly lower in the DADLE group than in the Control group (P < 0.01). The bile output after reperfusion was not significantly different between the two groups.
CONCLUSIONS: DADLE protects against I-R injury in hepatocytes, but not in the sinusoidal endothelial cells of the liver in rats. An anti-oxidative effect is suggested to be responsible for this effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678701     DOI: 10.1016/s0022-4804(03)00196-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Potential for discovery of neuroprotective factors in serum and tissue from hibernating species.

Authors:  Austin P Ross; Kelly L Drew
Journal:  Mini Rev Med Chem       Date:  2006-08       Impact factor: 3.862

Review 2.  Molecular strategies used by hibernators: Potential therapeutic directions for ischemia reperfusion injury and preservation of human donor organs.

Authors:  E Soo; A Welch; C Marsh; D B McKay
Journal:  Transplant Rev (Orlando)       Date:  2019-10-18       Impact factor: 3.943

Review 3.  Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Authors:  Xiaozhou He; Harleen K Sandhu; Yilin Yang; Fei Hua; Nathalee Belser; Dong H Kim; Ying Xia
Journal:  Cell Mol Life Sci       Date:  2012-09-27       Impact factor: 9.261

Review 4.  Therapeutics administered during ex vivo liver machine perfusion: An overview.

Authors:  Julianna E Buchwald; Jing Xu; Adel Bozorgzadeh; Paulo N Martins
Journal:  World J Transplant       Date:  2020-01-18

5.  Possible protection of sinusoidal endothelial cells by endothelin B receptor during hepatic warm ischemia-reperfusion.

Authors:  Kyoko Mochizuki; Yasuharu Ohno; Takashi Kanematsu; Yasuko Sakurai-Yamashita; Masami Niwa; Yoshitaka Hishikawa; Takehiko Koji
Journal:  Surg Today       Date:  2007-05-28       Impact factor: 2.549

Review 6.  Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?

Authors:  Dongman Chao; Ying Xia
Journal:  Prog Neurobiol       Date:  2009-12-28       Impact factor: 11.685

7.  Effects of remifentanil on hemodynamics, liver function and ICAM-1 expression in liver cancer patients undergoing surgery.

Authors:  Qi Jiang; Xiuling Song; Zheng Chen; Conghui Wang; Huiyu Luo
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

8.  [D-Ala2, D-Leu5] Enkephalin Attenuates Hepatic Ischemia-Reperfusion Injury in Cirrhotic Rats.

Authors:  Jueying Liu; Yuan Wang; Qianling Pan; Xueqing Chen; Yifeng Qu; Hao Zhu; Li Zheng; Yinghui Fan
Journal:  Front Surg       Date:  2022-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.